Institutional investors purchased a net $5.1 million shares of VTUS during the quarter ended December 2012 and now own 66.09% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BROADFIN CAPITAL LLC Bought 1.8 Million shares of Ventrus Biosciences Inc
VISIUM ASSET MANAGEMENT LP Bought 1.0 Million shares of Ventrus Biosciences Inc